Ashurst has advised LGC on the deal.LGC sold its drug development solutions (DDS) business to Alliance Pharma, a US-based bioanalytical contract research organisation and an Ampersand…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
